← Back to the full Peptide Guide overview
Important Disclaimer — Read Before Using This Page
This information is not intended for use by unlicensed individuals or by licensed professionals who lack adequate training and experience in assessing patients for peptide or hormone therapy. All clinical decisions and dosing must be made in consultation with a licensed, experienced physician and a licensed, experienced compounding pharmacist, and should be supported by published clinical studies.
The information presented here has been compiled using Artificial Intelligence, statements from videos and websites by apparent qualified professionals, and available published research. We strongly encourage exhaustive independent research before considering any therapy. Anyone starting a medication they have never taken before should take an extremely conservative approach.
Nothing on this page or in these videos should be taken as medical advice. These materials are provided only to help begin your research. All dosing and treatment decisions should be made between you and your medical providers after proper evaluation. We are not affiliated with any of the doctors whose videos appear on this page.
Ipamorelin Compounded
Category: Growth Hormone Support — Selective Growth Hormone Secretagogue
How it works. Ipamorelin is a pentapeptide growth hormone secretagogue that works through the ghrelin receptor (GHS-R) in the pituitary, triggering a pulse of growth hormone release. What makes it the most-prescribed secretagogue in this class is its selectivity: unlike older GHRP compounds such as GHRP-2 and GHRP-6, ipamorelin produces a clean GH pulse with minimal stimulation of cortisol, prolactin, or appetite. That is the entire reason it displaced its predecessors in clinical practice—the same GH signal without the hormonal collateral damage.
Why a physician prescribes it. Ipamorelin is most commonly prescribed alongside a GHRH analog—CJC-1295, sermorelin, or tesamorelin—because the two mechanisms are complementary: the GHRH analog provides the background signal while ipamorelin adds the pulse, producing greater GH release than either alone. It is defensibly used for patients seeking improved sleep quality, recovery, lean-mass support, and gradual body-composition change. Because it does not meaningfully raise cortisol or appetite, it is often the better-tolerated half of the stack, and it is sometimes used on its own for patients who want the gentlest entry point into GH-axis support.
What to expect, and what to watch. Deeper sleep is the most consistently reported early effect, often within the first one to two weeks—a reproducible finding, because GH pulsatility is tightly linked to slow-wave sleep. Recovery, energy, skin texture, and body-composition shifts may follow over one to three months. Realistic expectations matter: this is physiologic stimulation, not exogenous growth hormone. Cautions mirror the class—active or recent cancer, pituitary disorders, diabetes or insulin resistance, edema, carpal tunnel symptoms, and untreated sleep apnea. Possible effects include head rush or flushing after injection, vivid dreams, mild water retention, and injection-site irritation.
Recommended Videos
Dr. Ashley Froese — This Is Not Covered — Muscle Builder or More? Dr Reviews Ipamorelin
TRT and Hormone Optimization — Ipamorelin Explained
Dr. Jones, DC — Dr. Explains Why CJC/IPA is KING of Growth Hormone Peptides
Video Sources & Independence
The videos linked on this page are provided solely for educational purposes. None of the physicians or channels featured are sponsored by, affiliated with, or compensated by NJ Weight Loss & Preventive Care Clinics, its physicians, or any individuals associated with our practice. We have selected these videos because they offer thoughtful, evidence-based discussion of mechanisms and clinical considerations. Viewers should evaluate all sources independently.
← Back to the full Peptide Guide overview · Peptide Dosing Reference →